The Genomic Age of Medicine Comes to Market
How have the rapid advancements and plummeting costs around technologies such as gene sequencing and gene editing led to transformation in the healthcare sector and beyond? Brett Winton, head of research at ARK Invest, explains.
Perspectives Podcast
The content of this page is for informational purposes only and is intended for institutional professionals with the analytical resources and tools necessary to interpret any performance information. Nothing herein is intended to recommend any product, tool or service. For all references to laws, rules or regulations, please note that the information is provided “as is” and does not constitute legal advice or any binding interpretation. Any approach to comply with regulatory or policy initiatives should be discussed with your own legal counsel and/or the relevant competent authority, as needed.